Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 3/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 3/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17570881 | 1.00 | HSD11B1 (0.36) | HSD11B1NPSR1MEN1KMT2AKDM4E | |
| SCHEMBL16221629 | 0.82 | HSD11B1 (0.32) | HSD11B1 | |
| SCHEMBL11351258 | 0.81 | KMT2A (0.33) | HSD11B1KMT2A | |
| SCHEMBL16221696 | 0.81 | KMT2A (0.33) | HSD11B1KMT2A | |
| SCHEMBL8083570 | 0.81 | KMT2A (0.33) | HSD11B1KMT2A | |
| SCHEMBL16221630 | 0.78 | PRSS1 (0.32) | HSD11B1KDM4ELMNASMN1; SMN2TP53 | |
| SCHEMBL14219148 | 0.78 | PRSS1 (0.32) | HSD11B1KDM4ELMNASMN1; SMN2TP53 | |
| SCHEMBL13783610 | 0.78 | PRSS1 (0.32) | HSD11B1KDM4ELMNASMN1; SMN2TP53 | |
| SCHEMBL2351624 | 0.78 | PRSS1 (0.32) | HSD11B1KDM4ELMNASMN1; SMN2TP53 | |
| SCHEMBL11240661 | 0.78 | PRSS1 (0.32) | HSD11B1KDM4ELMNASMN1; SMN2TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160068630-A1 | Process for Preparing Polycarbonates by Polymerization of Five-Membered-Ring Cyclic Carbonates | TOTAL RESEARCH & TECHNOLOGY FELUY (BE) | 2016-03-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160068630-A1 | Process for Preparing Polycarbonates by Polymerization of Five-Membered-Ring Cyclic Carbonates | CWC15, DKC1, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 | HSD11B1 23/4885NPSR1 2490/4885MEN1 1257/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.